Two New FDA-Approved Treatments for RKD

TRUTAKNA® (atacicept) has been FDA approved for IgAN, click to aprende más. FILSPARI® (sparsentan) has also been FDA approved for FSGS and more information is coming soon. Please visit our Patient Navigation tool for support.

RECURSOS

/

ENCUENTRA UN ESPECIALISTA

/

CONTACTO

FSGS Awareness Day 2026 

NephCure is proud to recognize the second annual FSGS Awareness Day on June 9, 2026, shining a light on focal segmental glomerulosclerosis (FSGS), a rare, progressive kidney disease that can lead to kidney failure if left untreated.

FSGS often develops quietly with symptoms that are easy to miss until serious damage has already occurred.

But now, there’s more reason for hope than ever before. In April, the first treatment for FSGS was approved by the FDA.
That means new conversations, new options, and new possibilities for people living with FSGS.

Download the FSGS Handbook to learn what to look for, what to ask your doctor, and what steps to take next.

Get the FSGS Handbook

A First for FSGS Patients: What the sparsentan Approval Means for You

During this live discussion, moderated by NephCure’s COO Lauren Eva and CEO Josh Tarnoff, leading physicians Drs. Kirk Campbell, Laura Mariani, and Howard Trachtman walked through what this sparsentan FDA approval means for the FSGS community. They also discussed who may benefit and what patients and families should know as they navigate next steps.

What is FSGS?

Focal segmental glomerulosclerosis (FSGS) is a disease that causes scarring in the kidney’s filtering units.

Over time, this damage can lead to:

  • Protein leaking into the urine
  • Swelling in the body
  • Declining kidney function

FSGS is a leading cause of nephrotic syndrome and can progress to kidney failure.

The earlier you understand your risk, the more options you may have, including newly available treatments.

Aprende más

Get the FSGS Handbook 

If you or someone you love is living with FSGS, having the right information can change everything.

NephCure’s FSGS Handbook gives you:

  • A clear breakdown of what FSGS is and how it progresses
  • Questions to ask your doctor about symptoms and treatment options
  • Guidance on navigating care, support, and next steps

Now that a treatment for FSGS is available, it’s more important than ever to be informed and proactive.

Download the Handbook

Share Your Voice

Help us spread the word about FSGS Awareness Day by sharing resources, starting conversations, and showing support for those affected. Download our FSGS Awareness Day Toolkit for ready-to-use graphics, captions, and tips. Use #FSGSDay26 and tag @NephCure to be part of the movement.

Download The toolkit

Recommended Financial Support Resources

As new treatment options become available for FSGS, there are programs that may help eligible patients better navigate access, affordability, and support services. Resources like The Assistance Fund (TAF) y Travere TotalCare for FILSPARI may provide financial assistance, educational resources, and treatment support for eligible individuals.

Explore TAF Support Learn About Travere TotalCare

Wear Your Support

Show your support and spark conversations this FSGS Awareness Day with our limited-edition t-shirt. Every shirt helps raise awareness of FSGS and supports efforts to improve patient care and research. Grab your FSGS Awareness T-shirt today and get 50% off with code: FSGSDAY26

Comprar ahora

Get Your Voice Heard

If you or someone you love is living with focal segmental glomerulosclerosis, we want to hear from you. Your experience matters and can help shape future programs, resources, events, and advocacy efforts at NephCure.Take our quick 2-minute survey to share your perspective and help us better support the FSGS community. 

Take The Survey

FSGS Patient Stories and Resources

Glomeruloesclerosis focal y segmentaria (FSGS)

Zane C.

El viaje de Zane con el síndrome nefrótico comenzó poco después de su primer cumpleaños, marcado por una hinchazón inexplicable y una cascada de consultas médicas. A pesar de las grandes esperanzas de remisión, los tratamientos iniciales con dosis altas de …

Hoja de hechos

Glomeruloesclerosis focal-segmentaria (FSGS)

Descripción general y síntomas: La glomeruloesclerosis focal y segmentaria (FSGS) es una enfermedad renal poco común caracterizada por una disfunción en la parte del riñón que filtra la sangre (glomérulos). Sólo algunos glomérulos se ven afectados...

Glomeruloesclerosis focal y segmentaria (FSGS)

kimberly q.

A Kimberly le diagnosticaron glomeruloesclerosis focal y segmentaria (FSGS) a la edad de 25 años. Kimberly concertó una cita con su médico debido a una gran hinchazón en sus piernas...

Glomeruloesclerosis focal y segmentaria (FSGS)

Kevin M.

En 2002, Kevin sufrió migrañas debilitantes. A medida que empeoraban, Kevin decidió ver a un médico y se enteró de que su...

Video

MCD versus FSGS: desglose del diagnóstico y el curso clínico

MCD and FSGS, two major causes of Nephrotic Syndrome, have aspects that resemble one another. Dr. Suneel Udani reviews the similarities and differences between MCD and FSGS and discusses the age-old question: are these two diseases the same?

Biogen Prevail Trial- Aveiro, Aveiro

Thank You to Our FSGS Awareness Day 2026 Sponsors

Regístrese para recibir las últimas actualizaciones de NephCure.

INSCRIBIRSE
Este campo es para fines de validación y no debe modificarse.